Japanese information and communication technology giant Fujitsu has jointly developed an ultra-high throughput drug discovery system it says can not only dramatically reduce R&D lead times but can also expand the screening universe to literally billions of virtual molecules.
At a time when drug development speeds are attracting global public attention amid the coronavirus pandemic, Fujitsu is developing the technology in a collaboration with US venture and Cloud Pharmaceuticals Inc
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?